"The only constant is change," as the old saying goes, but that seems to be particularly true in the past couple decades.
Competing Interests: The author has been involved in clinical trials of albendazole and nitazoxanide, and has received research funding for these trials from SmithKline Beecham Pharmaceuticals and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback